Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cibus Inc. (CBUS:NASDAQ), powered by AI.
Cibus Inc. is currently trading at $1.23. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cibus Inc. on Alpha Lenz.
View Cibus Inc.'s valuation metrics on Alpha Lenz.
“Cibus Inc.'s ROE is -223.0%. Explore profitability and growth together.”
Ask for details →Cibus Inc., a leading company within the bioscience sector, focuses on developing and commercializing sustainable agricultural solutions. The primary function of Cibus lies in its innovative gene-editing technology aimed at enhancing plant traits, thereby improving crop yield, resilience, and overall sustainability. Cibus leverages its proprietary Rapid Trait Development System (RTDS) to address food security and agricultural efficiency, making it a key player in the production of non-GMO, improved crop varieties. These advancements cater to a variety of industries, notably agriculture and food production, promoting sustainable practices aligned with global environmental strategies. Headquartered in the biotech hub of San Diego, Cibus collaborates with seed companies and agricultural producers worldwide, providing solutions that respond to the ongoing demand for increased agricultural productivity without compromising environmental concerns. By playing a crucial role in modern crop management, Cibus Inc. supports the drive towards a more sustainable and efficient agricultural economy, contributing significantly to the evolving landscape of global food supply and security.
“Cibus Inc.'s ROE is -223.0%. Explore profitability and growth together.”
Ask for details →Cibus Inc. (ticker: CBUS) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 157 employees.
The current price is $1.23 with a P/E ratio of -x and P/B of -x.
ROE is -222.98% and operating margin is -1853.92%. Annual revenue is $4M.